Inspiratory Muscle Training for Exercise-Induced Asthma
(IMT_EIB Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether inspiratory muscle training (IMT) can alleviate exercise-induced asthma symptoms and enhance cycling performance. Participants will use the PrO2Fit device, an inspiratory muscle trainer, to strengthen their breathing muscles and determine if this reduces asthma symptoms and improves cycling ability. The study includes two groups: one using a high-resistance training model and the other using a lower-resistance model for comparison. It seeks competitive athletes with mild to moderate asthma or exercise-induced asthma who have cycled for at least 1-2 years. As an unphased trial, this study offers a unique opportunity to contribute to research that could improve athletic performance and asthma management.
Will I have to stop taking my current medications?
Yes, you will need to stop taking certain medications. The trial excludes participants who are currently taking asthma maintenance medications, SSRIs, ADHD medication, and those who chronically consume pain medication.
What prior data suggests that the PrO2Fit Device is safe for inspiratory muscle training?
Research shows that inspiratory muscle training (IMT), such as that used with the PrO2Fit device, is generally safe for people with asthma. One study demonstrated that a 6-month IMT program strengthened and increased the endurance of breathing muscles in 20 patients with moderate asthma, indicating good tolerance. Another study found that eight weeks of IMT improved muscle strength and endurance in individuals with bronchiectasis, another lung condition, without major safety issues. These findings suggest that using the PrO2Fit device for IMT is generally safe. However, as with any treatment, individual experiences may vary. Participants should monitor their body's responses and discuss any concerns with the study team during the trial.12345
Why are researchers excited about this trial?
Researchers are excited about the Inspiratory Muscle Training (IMT) for exercise-induced asthma because it offers a novel approach by strengthening the muscles used for breathing. Unlike traditional treatments that often focus on medication to manage symptoms, this method aims to enhance the body's natural breathing efficiency through targeted muscle exercises. The PrO2Fit device used in the training allows for precise control and monitoring of inspiratory pressure, making the training more effective and tailored to individual needs. This approach could lead to improved exercise tolerance and reduced asthma symptoms without the reliance on medication.
What evidence suggests that the PrO2Fit Device is effective for exercise-induced asthma?
Research has shown that inspiratory muscle training (IMT) can help people with exercise-induced asthma by strengthening their breathing muscles. Studies have found that IMT boosts breathing power and stamina, making exercise easier. One study showed that after eight weeks of IMT, participants had better lung function and felt more capable during physical activities. Another study reported significant improvements in breathing muscle strength and reduced breathlessness. In this trial, participants in the Inspiratory Muscle Training (IMT) group will use the PrO2Fit device, which may effectively manage exercise-induced asthma symptoms.12346
Who Is on the Research Team?
Tim Mickleborough, Ph.D.
Principal Investigator
Indiana University
Are You a Good Fit for This Trial?
This trial is for competitive recreational or college athletes aged 18-35 with mild to moderate persistent asthma or EIB, a BMI of 18.5-28, and at least 1-2 years of cycling experience. They must have an FEV1 >65% predicted and not be on asthma maintenance meds, SSRIs, ADHD meds, painkillers regularly, fish oil supplements, nor have cardiovascular or other specified diseases.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo inspiratory muscle training (IMT) or sham IMT for 8 weeks, focusing on improving inspiratory muscle strength and endurance.
Follow-up
Participants are monitored for changes in exercise-induced bronchoconstriction severity, inspiratory muscle strength, and cycling performance.
What Are the Treatments Tested in This Trial?
Interventions
- PrO2Fit Device
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor